Detection of Factor V Leiden from a Drop of Blood by PCR-SSCP

Summary

Recently, a point mutation in the coagulation Factor V gene (G to A in position 1691) has been identified which makes the mutant Factor V (called Factor V Leiden) resistant to activated protein C. This defect is a well established genetic risk factor in venous thrombosis. Because of the high prevalence of Factor V Leiden in normal population (2-7%), it would be reasonable to perform a rapid and simple method for screening the genetic abnormality in population at risk.

We have developed a simple, reproducible, rapid and cheap procedure that, using PCR and SSCP, allows the identification of the mutation responsible for Factor V Leiden. Specificity of this method has been tested in 319 samples: 304 normal, 14 heterozygous and 1 homozygous for Factor V Leiden. This assay allows non-isotopic Factor V Leiden identification by using frozen whole blood in 3 h. All these features make this test adequate for routine screening of this mutation in a large number of samples.

• References

• 1 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
• 2 Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Büller HR, Van-denbroucke JP. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593-1596
• 3 Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993; 324: 1503-1506
• 4 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-521
• 5 Beauchamp NJ, Daly ME, Hampton KK, Cooper PC, Preston FE, Peake IR. High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis. Br J Haematol 1994; 88: 219-222
• 6 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134
• 7 Dahlbäck B. Resistance to activated protein C, the Arg 506 to Gin in the factor V gene, and venous thrombosis. Functional test and DNA-based assays, pros and cons. Thromb Haemost 1995; 73: 739-742
• 8 Ehrenforth S, Radtke KP, Scharrer I. Acquired activated protein C-resis-tance in patients with lupus anticoagulants. Thromb Haemost 1995; 74: 793-810
• 9 Leroy-Matheron C, Levent M, Pignon J-M, Mendoca C, Gouault-Heilmann M. The 1691 G - A mutation in the factor V gene: relationship to activated protein C (APC) resistance and thrombosis in 65 patients. Thromb Haemost 1996; 75: 4-10
• 10 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsman PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
• 11 Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the factor V Arg506 - Gin mutation. Blood Coagulation and Fibrinol 1995; 6: 245-248
• 12 van de Locht LTF, Kuypers AWHM, Verbruggen BW, Linssen PCM, Novakova IRO, Mensink EJBM. Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis. Thromb Haemost 1995; 74: 1276-1279
• 13 Rabes JP, Trossaert M, Conard J, Giraudet P, Boileau C. Single point mutation at Arg (506) of factor V associated with APC resistance and venous thromboembolism: improved detection by PCR-mediated site-directed mutagenesis. Thromb Haemost 1995; 74: 1379
• 14 Kirschbaum NE, Foster PA. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance. Thromb Haemost 1995; 74: 874-878
• 15 Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-2770
• 16 Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-917
• 17 Ohhara M, Kurosu Y, Esumi M. Direct PCR of whole blood and hair shafts by microwave treatment. Biotechniques 1994; 17: 727-728
• 18 Panaccio M, Lew AM. PCR based diagnosis in the presence of 8% (v/v) blood. Nucleic Acids Res 1991; 19: 1151
• 19 Panaccio M, Georgesz M, Lew AM. FoLT PCR: a simple PCR protocol for amplifying DNA directly from whole blood. Biotechniques 1993; 14: 238-243
• 20 Hayasi K. PCR-SSCP: a method for detection of mutations. GATA 1992; 9: 73-79
• 21 Ainsworth PJ, Surh LC, Coulter-Mackie MB. Diagnostic single strand conformational polymorphism (SSCP): a simplified non-radioisotopic method as applied to a Tay-Sachs B1 variant. Nucleic Acid Res 1991; 19: 405-406
• 22 Dockhom-Dworniczak B, Dwomiczak B, Brommelkamp L, Bulles J, Horst J, Bocker WW. Non-isotopic detection of single strand conformation polymorphism (PCR-SSCP): a rapid and sensitive technique in diagnosis of phenylketonuria. Nucleic Acids Res 1991; 19: 2500
• 23 Mohabeer AJ, Hiti AL, Martin WJ. Non-radioactive single strand conformation polymorphism (SSCP) using the Pharmacia “Phastsystem”. Nucleic Acid Res 1991; 19: 3154